Natco Pharma's Generic Risdiplam: A Ray of Hope for SMA Patients in India!

Unknown Apr 02, 2026 1,000 Views

Natco Pharma has made an announcement to make available its generic equivalent of Risdiplam, a vital medication for spinal muscular atrophy (SMA) treatment, at a reasonable cost of Rs 15,900 per unit. This step will make the treatment more affordable to patients who now depend on the costly versi...